![Structural Heart Disease Structural Heart Disease](/gehcstorefront/_ui/desktop/theme-green/images/missing-product-new-2024-300x300.jpg)
![Structural Heart Disease Structural Heart Disease](/gehcstorefront/_ui/desktop/theme-green/images/missing-product-new-2024-300x300.jpg)
Structural Heart Disease
GEHC-SHSCA-DRSE-SHD-UN9012 | |
Clinical Training | |
GE HealthCare | |
Enter your approval number and submit to add item(s) to cart.
Please enter approval number
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without the
approval number, GE will contact you before your order
can be confirmed for shipment.
Select your approver's name and submit to add item(s) to your cart
Please Select Approver Name
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without
selecting an approver, GE will contact you before your order
can be confirmed for shipment.
Product Overview
Structural heart diseases is either caused by degeneration of valves and vessels of heart, or they can be congenital in nature. By the end of this program, the participant should be able to: 1. Understand the guidelines for management of congenital heart disease, acute coronary syndrome / non-ST elevation MI and ST elevation myocardial infarction (STEMI) in Indian population; 2. Understand clinical practice guidelines of European Society of cardiology (ESC) and European Association for Cardio-thoracic Surgery (EACTS) with the level of evidence and classes of recommendation for cardiovascular disease (CAD); 3. Apply the World Health Organization recommendations to provide guidance on which preventive action to initiate, and the degree of intensity for cardiac heart disease (CHD) and cerebrovascular disease (CVD); and 4. Understand the guidelines of AHA/ACC for the Clinical diagnosis and management of patients with valvular heart disease (VHD).